“…In the present work, the in vitro concentrations of ketamine for inhibiting the effect of various secretagogues used in the rat perfused adrenal medulla are not much different from those attained in vivo in laboratory animals and humans (Dowdy & Kaya, 1968: Traber et al, 1968Goldberg et al, 1970: Yamanaka & Dowdy, 1974Schwartz & Horwitz et al, 1975;McGrath et al, l975;Diaz et al 1976;Kolka et al, 1983;Sumikawa et al, 1983;Purifoy & Holz, 1984;Takara et al, 1986).…”